Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tipifarnib in Myelofibrosis With Myeloid Metaplasia
NCT00047190Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Aug 2002
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tipifarnib in myelofibrosis with myeloid metaplasia (MMM), sponsored by National Cancer Institute. Started Aug 2002; status: completed.
02
Drugs
tipifarnib
03
Conditions
myelofibrosis with myeloid metaplasia (MMM)
Beyond the preview
Go deeper on NCT00047190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00047190.